Abstract
The successful management of right ventricular dysfunction is a complex process and relies for its success on the identification, diagnosis and treatment of the underlying pathophysiological process. Pulmonary hypertension remains an area of significant clinical concern and active research. New pharmacological and mechanical treatment modalities are focusing on the successful reduction of PVR (without systemic hypotension) with subsequent preservation of right ventricular function.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
